ALPS Advisors’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-72,484
| Closed | -$3.56M | – | 923 |
|
|
2018
Q3 | $3.56M | Buy |
72,484
+13,370
| +23% | +$657K | 0.02% | 188 |
|
|
2018
Q2 | $1.9M | Buy |
59,114
+4,701
| +9% | +$151K | 0.01% | 234 |
|
|
2018
Q1 | $1.7M | Buy |
54,413
+9,457
| +21% | +$295K | 0.01% | 227 |
|
|
2017
Q4 | $2.05M | Buy |
44,956
+5,225
| +13% | +$238K | 0.01% | 195 |
|
|
2017
Q3 | $1.49M | Buy |
39,731
+3,546
| +10% | +$133K | 0.01% | 207 |
|
|
2017
Q2 | $1.73M | Buy |
36,185
+4,008
| +12% | +$191K | 0.01% | 191 |
|
|
2017
Q1 | $1.47M | Sell |
32,177
-3,766
| -10% | -$172K | 0.01% | 189 |
|
|
2016
Q4 | $1.16M | Sell |
35,943
-11,581
| -24% | -$374K | 0.01% | 208 |
|
|
2016
Q3 | $1.63M | Sell |
47,524
-4,688
| -9% | -$160K | 0.01% | 198 |
|
|
2016
Q2 | $1.76M | Buy |
52,212
+10,542
| +25% | +$356K | 0.02% | 178 |
|
|
2016
Q1 | $2.21M | Sell |
41,670
-6,752
| -14% | -$358K | 0.02% | 148 |
|
|
2015
Q4 | $3.72M | Sell |
48,422
-8,938
| -16% | -$686K | 0.04% | 135 |
|
|
2015
Q3 | $23.6K | Buy |
57,360
+21,190
| +59% | +$8.71K | 0.02% | 156 |
|
|
2015
Q2 | $2.56M | Buy |
36,170
+18,135
| +101% | +$1.28M | 0.02% | 150 |
|
|
2015
Q1 | $1.6M | Buy |
+18,035
| New | +$1.6M | 0.01% | 161 |
|